Improvements in Health Status with Revefenacin, a Once-Daily, Nebulized, Long-Acting Muscarinic Antagonist for Chronic Obstructive Pulmonary Disease.
Respiratory Medicine（2023）
Key words
Clinical COPD Questionnaire,COPD,COPD Assessment Test,Patient-reported outcomes,Revefenacin,St. George's Respiratory Questionnaire
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined